BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29901570)

  • 1. Skene's Glands Adenocarcinoma: A Series of 4 Cases.
    Tregnago AC; Epstein JI
    Am J Surg Pathol; 2018 Nov; 42(11):1513-1521. PubMed ID: 29901570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skene's gland adenocarcinoma with intestinal differentiation: A case report and literature review.
    Muto M; Inamura K; Ozawa N; Endo T; Masuda H; Yonese J; Ishikawa Y
    Pathol Int; 2017 Nov; 67(11):575-579. PubMed ID: 28872768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First Molecular Genetic Characterization of Skene's Gland Adenocarcinoma.
    Lenz J; Michal M; Michal M; Hes O; Konečná P; Lenz D
    Int J Surg Pathol; 2021 Jun; 29(4):447-453. PubMed ID: 32795117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skene's gland adenocarcinoma with increased serum level of prostate-specific antigen.
    Dodson MK; Cliby WA; Keeney GL; Peterson MF; Podratz KC
    Gynecol Oncol; 1994 Nov; 55(2):304-7. PubMed ID: 7525428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate specific antigen and prostate specific acid phosphatase in adenocarcinoma of Skene's paraurethral glands and ducts.
    Zaviacic M; Sidlo J; Borovský M
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):503-5. PubMed ID: 7507278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skene's Gland Malignancy: A Case Report and Systematic Review.
    Slopnick EA; Bagby C; Mahran A; Nagel C; Garcia J; El-Nashar S; Hijaz AK
    Urology; 2022 Jul; 165():36-43. PubMed ID: 35192863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Rare Case of Skene's Gland Adenocarcinoma.
    Kyriazis G; Varughese A; Rodrigues G; Simms M
    Clin Genitourin Cancer; 2020 Jun; 18(3):e300-e302. PubMed ID: 31883942
    [No Abstract]   [Full Text] [Related]  

  • 8. Skene's gland adenocarcinoma resembling prostatic adenocarcinoma.
    Pongtippan A; Malpica A; Levenback C; Deavers MT; Silva EG
    Int J Gynecol Pathol; 2004 Jan; 23(1):71-4. PubMed ID: 14668555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Female urethral adenocarcinoma: evidence for more than one tissue of origin?
    Dodson MK; Cliby WA; Pettavel PP; Keeney GL; Podratz KC
    Gynecol Oncol; 1995 Dec; 59(3):352-7. PubMed ID: 8522254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasizing adenocarcinoma of the female prostate (Skene's paraurethral glands). Histological and immunohistochemical prostate markers studies and first ultrastructural observation.
    Sloboda J; Zaviacic M; Jakubovský J; Hammar E; Johnsen J
    Pathol Res Pract; 1998; 194(2):129-36. PubMed ID: 9584326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen response after definitive radiotherapy for Skene's gland adenocarcinoma resembling prostate adenocarcinoma.
    Korytko TP; Lowe GJ; Jimenez RE; Pohar KS; Martin DD
    Urol Oncol; 2012 Sep; 30(5):602-6. PubMed ID: 20870432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female urethral adenocarcinoma: immunohistochemical evidence of more than 1 tissue of origin.
    Murphy DP; Pantuck AJ; Amenta PS; Das KM; Cummings KB; Keeney GL; Weiss RE
    J Urol; 1999 Jun; 161(6):1881-4. PubMed ID: 10332458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misplaced Skene's glands: glandular elements in the lower female genital tract that are variably immunoreactive with prostate markers and that encompass vaginal tubulosquamous polyp and cervical ectopic prostatic tissue.
    Kelly P; McBride HA; Kennedy K; Connolly LE; McCluggage WG
    Int J Gynecol Pathol; 2011 Nov; 30(6):605-12. PubMed ID: 21979599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skene's Gland Derivatives in the Female Genital Tract and Cervical Adenoid Basal Carcinoma are Consistently Positive With Prostatic Marker NKX3.1.
    Hawari R; Fernandes L; Park KJ; McCluggage WG
    Int J Gynecol Pathol; 2021 Jul; 40(4):400-407. PubMed ID: 33021555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIN-like (Ductal) Adenocarcinoma of the Prostate.
    Paulk A; Giannico G; Epstein JI
    Am J Surg Pathol; 2018 Dec; 42(12):1693-1700. PubMed ID: 30138215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female urethral carcinoma: evidences to origin from Skene's glands.
    Reis LO; Billis A; Ferreira FT; Ikari LY; Stellini RF; Ferreira U
    Urol Oncol; 2011; 29(2):218-23. PubMed ID: 19450996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosquamous Carcinoma of Skene's Gland: A Case Report and Literature Review.
    Gao Q; Liu X; Ye L; Lv T; Teng Y; Lan J; Li T; Tian M; Chen J; He S; Xie S; Zou Y
    Front Oncol; 2022; 12():893980. PubMed ID: 36016628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Female prostate cancer?].
    Thum S; Haben B; Christ G; Sen Gupta R
    Pathologe; 2017 Sep; 38(5):448-450. PubMed ID: 28730423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.